欧米德内帕格异在拉塔诺普罗斯特中 低/不响应 初级开放角眼光或眼睛高血压的患者:第三阶段,非随机,两阶段,开放标签研究
Joseph F Panarelli1, Eileen C Bowden2, Michael E Tepedino3
1NYU Langone Eye Center, New York, NY.
Journal of glaucoma
|October 19, 2023
概括
奥米德内帕格异 (OMDI) 有效地降低了初级开角玻璃眼瘤 (POAG) 或眼睛高血压 (OHT) 的患者的眼内压力,这些患者对拉坦诺的反应不佳. 这项研究证实了OMDI.
科学领域:
- 眼科医生 眼科 眼科
- 玻璃眼研究研究 玻璃眼研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 主要开角青光眼 (POAG) 和眼睛高血压 (OHT) 是常见的疾病,通常使用前列腺素类似物进行治疗.
- 拉坦诺普罗斯特是一种广泛使用的前列腺素类似物,用于降低眼内压力 (IOP).
- 一些患者对拉坦诺普罗斯特的反应很低或没有反应,需要替代治疗.
研究的目的:
- 评估omidenepag isopropyl (OMDI) 在POAG或OHT患者的疗效和安全性.
- 具体评估OMDI在那些对latanoprost没有充分反应的个体的性能.
主要方法:
- 一项第三期,开放标签,多中心研究,涉及107名患有POAG或OHT的患者.
- 患者接受了拉坦诺普罗斯特的运行期,随后是每天一次OMDI 0.002%治疗3个月.
- 主要终点是从基线在3个月的平均每日 (MD) 眼内压力 (IOP) 的变化.
主要成果:
- 在3个月的OMDI治疗后,在拉坦诺普罗斯特低/不响应患者中观察到平均额外的IOP降低为2.96 mm Hg.
- 治疗耐受性良好,没有报告任何重大安全问题.
- 70.1%的患者患有POAG,29.9%患有OHT,63.6%以前使用过前列腺素类似物.
结论:
- 奥米德内帕格异 (OMDI) 在POAG或OHT的患者中显示出显著的IOP降低效果,这些患者的拉坦诺水平低/不反应.
- 对于这种特定的患者群体来说,OMDI是一种安全有效的治疗选择.
- 进一步的研究可能会探索长期的疗效和安全性.
相关概念视频
Open Angle Glaucoma: Treatment
459
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
459
Angle Closure Glaucoma: Treatment
536
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
536
Glaucoma: Overview
599
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
599
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
192
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
192


